At this time, posts about ST Pharm are rapidly increasing on portals and securities communities. Today, foreigners have tentatively purchased a net 1,000 shares of ST Pharm, while institutions have sold a net 2,000 shares. ST Pharm is known as a company specializing in active pharmaceutical ingredients.


As of 12:30 PM on the 9th, ST Pharm's stock price is 103,800 KRW, down 6.91% from the previous day, with a trading volume of 1,068,150 shares, which is about 43.2% of the 5-day average trading volume. On December 4th, ST Pharm became a market issue with the headline 'Surge in ST Pharm due to production of Pfizer vaccine m-RNA key raw materials.'


In addition to ST Pharm, posts by investors are also rapidly increasing for Jangwon Tech (174880), Jeil Pharm (271980), and Jaan (221610).



※Source: AI Investment Assistant AI Lassiro


※ This article was generated in real-time by an article automatic generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing